IDH1 and central nervous system cancer: Three IDH1 mutant glioma models, including human glioma xenografts in mice, cultured glioma cell lines and human glioma biopsies, showed a distinct phospholipid profile characterized by low levels of phosphoethanolamine and heightened levels of phosphatidylcholine [113].